Gonzalez-Ericsson PI, Stovgaard ES, Sua LF, Reisenbichler E, et al. The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice. J Pathol 2020 Mar 4. doi: 10.1002/path.5406.
PMID: 32129476